| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.007 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.007 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.46 | 0.008 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.008 |